IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023
IQVIA Holdings Inc. (NYSE: IQV) will announce its fourth-quarter and full-year 2022 financial results on February 10, 2023, before market opens. The management team will host a conference call at 9:00 a.m. Eastern Time the same day. Investors can access the earnings release and related financial information on the IQVIA Investor Relations website. To participate in the call, prior registration is required. A replay of the webcast will be available two hours post-event. IQVIA is a leading global provider of analytics, technology solutions, and clinical research services, employing approximately 86,000 staff across over 100 countries.
- Scheduled earnings release for Q4 and full-year 2022, which may provide insight into financial health.
- Host of conference call allows for direct communication with investors.
- None.
To listen to the event and view the presentation slides via webcast, join from the IQVIA Investor Relations website at http://ir.iqvia.com. To participate in the conference call, interested parties must register in advance by clicking on this link. Following registration, participants will receive a confirmation email containing details on how to join the conference call, including the dial-in and a unique passcode and registrant ID. At the time of the live event, registered participants can connect to the call using the information provided in the confirmation email and will be placed directly into the call.
A replay of the webcast will be available approximately two hours after the conclusion of the live event. To access the webcast recording, visit http://ir.iqvia.com.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 86,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
IQVIAFIN
View source version on businesswire.com: https://www.businesswire.com/news/home/20230125005606/en/
+1.973.316.3828
+1.919.780.3221
Source: IQVIA
FAQ
When will IQVIA announce its 2022 financial results?
What time is the IQVIA conference call for financial results?
Where can I find the IQVIA earnings release?
How can I participate in the IQVIA conference call?
Will a replay of the IQVIA earnings call be available?
